Summary of Significant Accounting Policies (Tables)
|
6 Months Ended |
Jun. 30, 2025 |
|---|
| Accounting Policies [Abstract] |
|
| Schedule of Cash and Cash Equivalents |
The following table provides a reconciliation of cash and cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands): | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | Cash and cash equivalents | $ | 283,580 | | | $ | 161,435 | | | Restricted cash | 6,148 | | | 6,137 | | | Total cash, cash equivalents and restricted cash | $ | 289,728 | | | $ | 167,572 | |
|
| Schedule of Restrictions on Cash and Cash Equivalents |
The following table provides a reconciliation of cash and cash equivalents and restricted cash within the condensed consolidated balance sheets that sum to the total of the same on the condensed consolidated statement of cash flows (in thousands): | | | | | | | | | | | | | June 30, 2025 | | December 31, 2024 | | Cash and cash equivalents | $ | 283,580 | | | $ | 161,435 | | | Restricted cash | 6,148 | | | 6,137 | | | Total cash, cash equivalents and restricted cash | $ | 289,728 | | | $ | 167,572 | |
|
| Schedule of Earnings Per Share, Basic and Diluted |
The following table presents the calculation of basic and diluted net income (loss) per share (in thousands, except shares and per share data): | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | | Net income (loss) from continuing operations | $ | (8,026) | | | $ | (25,833) | | | $ | 180,462 | | | $ | (82,162) | | Less: net (income) loss attributable to non-controlling interest | (4) | | | 455 | | | 1 | | | 1,029 | | | Net income (loss) from continuing operations available to common shareholders | (8,030) | | | (25,378) | | | 180,463 | | | (81,133) | | | Net income (loss) from discontinued operations, net of tax | — | | | 106 | | | — | | | (149) | | | Net income (loss) attributable to common shareholders - basic | $ | (8,030) | | | $ | (25,272) | | | $ | 180,463 | | | $ | (81,282) | | Add: Dilutive effect of convertible notes, net (1) | — | | | — | | | 5,562 | | | — | | Net income (loss) attributable to common shareholders - diluted | $ | (8,030) | | | $ | (25,272) | | | $ | 186,025 | | | $ | (81,282) | | | | | | | | | | | Denominator: | | | | | | | | | Weighted-average common shares outstanding - basic | 341,683,408 | | | 311,253,856 | | | 341,372,099 | | | 305,339,121 | | | Convertible notes | — | | | — | | | 46,266,486 | | | — | | Common stock options and restricted stock units | — | | | — | | | 15,315,291 | | | — | | | Weighted-average common shares outstanding - diluted | 341,683,408 | | | 311,253,856 | | | 402,953,876 | | | 305,339,121 | | | | | | | | | | | Net income (loss) per share - basic | | | | | | | | | Continuing operations | $ | (0.02) | | | $ | (0.08) | | | $ | 0.53 | | | $ | (0.27) | | | Discontinued operations | $ | — | | | $ | — | | | $ | — | | | $ | — | | | Total net income (loss) per share - basic | $ | (0.02) | | | $ | (0.08) | | | $ | 0.53 | | | $ | (0.27) | | | | | | | | | | | Net income (loss) per share - diluted | | | | | | | | | Continuing operations | $ | (0.02) | | | $ | (0.08) | | | $ | 0.46 | | | $ | (0.27) | | | Discontinued operations | $ | — | | | $ | — | | | $ | — | | | $ | — | | | Total net income (loss) per share - diluted | $ | (0.02) | | | $ | (0.08) | | | $ | 0.46 | | | $ | (0.27) | |
(1) Reflects interest expense incurred, net of tax, associated with convertible note activity during the period as evaluated under the if-converted method. |
| Schedule of Antidilutive Securities Excluded from Computation of Earnings per Share |
The following common share equivalents are excluded from the calculation of weighted average common shares outstanding because their inclusion would have been anti-dilutive: | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
June 30, | | Six Months Ended
June 30, | | | 2025 | | 2024 | | 2025 | | 2024 | | | Warrants to purchase common stock | 166,667 | | | 166,670 | | | 166,667 | | | 166,670 | | | | Stock options | 16,597,598 | | | 18,859,624 | | | 14,964,036 | | | 18,859,624 | | | | Unvested restricted stock units | 33,072,678 | | | 23,066,094 | | | 2,113,384 | | | 23,066,094 | | | | Convertible notes variable settlement feature | 48,771,938 | | | 49,115,898 | | | 2,505,452 | | | 49,115,898 | | | | Total | 98,608,881 | | | 91,208,286 | | | 19,749,539 | | | 91,208,286 | | |
|